Innoquest

Innoquest Diagnostics, formed in March 2021 from the merger of Quest Laboratories and Innovative Diagnostics, is a leading clinical diagnostics provider in Singapore with over 27 years of combined experience. Operating from eight facilities, Innoquest is the largest independent diagnostic service provider in the country, handling over 3 million patient referrals annually. The main laboratory, located at Starhub Green, processes tests for more than 15,000 patients daily with advanced automation. Innoquest emphasizes high-quality diagnostics, holding dual accreditations from the College of American Pathologists (CAP) and the Singapore Laboratory Accreditation Scheme (ISO 15189).

Focused on expanding its test offerings, especially in genetic testing for early cancer detection, and automating processes for improved efficiency, Innoquest has also expanded its operations to the Philippines, Indonesia, and Vietnam under Pathology Asia Holdings. Future plans include adopting innovative technologies such as digital pathology and artificial intelligence to enhance diagnostic speed and quality. In collaboration with Nightingale Health, Innoquest aims to introduce advanced blood analysis technology in Southeast Asia, offering comprehensive health risk assessments. Innoquest remains a pivotal player in the Southeast Asian healthcare sector, dedicated to innovation, quality, and comprehensive service delivery.